AlphaCentric Advisors LLC
- SEC CIK
- 0001913464
- Latest filing
- Jul 24, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed Apr 24, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 228
- +12 vs. Q4 2023
- Portfolio value
- $165.8M
- +$16.8M (+11.3%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| PFEPfizer Inc | Stock | 175,000 | $4.86M | 2.9% | +95,000+118.8% | Added | History |
| RITMRithm Capital Corp. | REIT | 420,966 | $4.70M | 2.8% | +20,000+5.0% | Added | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 122,000 | $4.10M | 2.5% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 16,000 | $3.68M | 2.2% | +16,000 | New | History |
| PCRXPacira BioSciences, Inc. | COM | 117,500 | $3.43M | 2.1% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 675,000 | $3.43M | 2.1% | 00.0% | Unchanged | History |
| LKFTLakefront Biotherapeutics NV | SPON ADR | 105,000 | $3.38M | 2.0% | 00.0% | Unchanged | History |
| ARGXArgenx SE | SPONSORED ADR | 8,000 | $3.15M | 1.9% | +250+3.2% | Added | History |
| Two HBRS Invt Corp90187BAB7 | NOTE 6.250% 1/1 | 3,205,000 | $3.04M | 1.8% | 00.0% | Unchanged | – |
| NARIInari Medical, Inc. | Stock | 63,000 | $3.02M | 1.8% | +58,000+1,160.0% | Added | History |
| DCGODocGo Inc. | COM | 650,000 | $2.63M | 1.6% | +340,000+109.7% | Added | History |
| ONCBeOne Medicines Ltd. | ADR | 16,750 | $2.62M | 1.6% | +9,250+123.3% | Added | History |
| EFCEllington Financial Inc. | COM | 221,602 | $2.62M | 1.6% | 00.0% | Unchanged | History |
| AXSMAxsome Therapeutics, Inc. | COM | 32,500 | $2.59M | 1.6% | +32,500 | New | History |
| MTGMgic Investment Corp | COM | 114,379 | $2.56M | 1.5% | +35,000+44.1% | Added | History |
| QUREuniQure N.V. | SHS | 460,000 | $2.39M | 1.4% | +38,975+9.3% | Added | History |
| CHRSCoherus Oncology, Inc. | COM | 1,000,000 | $2.39M | 1.4% | 00.0% | Unchanged | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 94,000 | $2.36M | 1.4% | +44,000+88.0% | Added | History |
| DXDynex Capital Inc | COM | 181,492 | $2.26M | 1.4% | 00.0% | Unchanged | History |
| URGNUroGen Pharma Ltd. | COM | 143,898 | $2.16M | 1.3% | −11,102−7.2% | Reduced | History |
| CORTCorcept Therapeutics Inc | COM | 85,000 | $2.14M | 1.3% | +85,000 | New | History |
| CATXPerspective Therapeutics, Inc. | COM | 1,756,756 | $2.09M | 1.3% | +1,756,756 | New | History |
| FOLDAmicus Therapeutics, Inc. | COM | 175,000 | $2.06M | 1.2% | +35,000+25.0% | Added | History |
| EXASExact Sciences Corp | COM | 29,000 | $2.00M | 1.2% | +29,000 | New | History |
| Pennymac Corp70932AAD5 | NOTE 5.500%11/0 | 1,965,000 | $1.94M | 1.2% | 00.0% | Unchanged | – |
| MFAMfa Financial, Inc. | COM | 167,725 | $1.91M | 1.2% | +25,000+17.5% | Added | History |
| RWTRedwood Trust Inc | COM | 288,343 | $1.84M | 1.1% | +141,750+96.7% | Added | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 60,000 | $1.82M | 1.1% | +20,000+50.0% | Added | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 42,500 | $1.80M | 1.1% | +17,500+70.0% | Added | History |
| MDTMedtronic plc | Stock | 20,500 | $1.79M | 1.1% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM | 1,125,000 | $1.70M | 1.0% | 00.0% | Unchanged | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 38,500 | $1.62M | 1.0% | +38,500 | New | History |
| Invesco Exchange Traded FD T46137V258 | S&P500 PUR VAL | 17,834 | $1.58M | 1.0% | +17,834 | New | – |
| STXSStereotaxis, Inc. | COM NEW | 600,000 | $1.57M | 0.9% | 00.0% | Unchanged | History |
| iShares Russell 1000 Value ETF464287598 | ETF | 8,671 | $1.55M | 0.9% | +8,671 | New | – |
| KALVKalVista Pharmaceuticals, Inc. | COM | 130,000 | $1.54M | 0.9% | −7,000−5.1% | Reduced | History |
| DVAXDynavax Technologies Corp | COM NEW | 122,500 | $1.52M | 0.9% | +22,500+22.5% | Added | History |
| GSKGSK plc | ADR | 35,000 | $1.50M | 0.9% | 00.0% | Unchanged | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 60,000 | $1.49M | 0.9% | +60,000 | New | History |
| AVBPArriVent BioPharma, Inc. | COM | 83,000 | $1.48M | 0.9% | +83,000 | New | History |
| EMBCEmbecta Corp. | Stock | 111,500 | $1.48M | 0.9% | −88,500−44.3% | Reduced | History |
| VKTXViking Therapeutics, Inc. | COM | 18,000 | $1.48M | 0.9% | +18,000 | New | History |
| ADAMAdamas Trust, Inc. | COM | 200,963 | $1.45M | 0.9% | 00.0% | Unchanged | History |
| SNPSSynopsys Inc | COM | 2,500 | $1.43M | 0.9% | +400+19.0% | Added | History |
| TRMLTourmaline Bio, Inc. | COM | 61,100 | $1.40M | 0.8% | +61,100 | New | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 20,000 | $1.38M | 0.8% | 00.0% | Unchanged | History |
| YARWYarrow Bioscience, Inc. | COM | 445,000 | $1.37M | 0.8% | −223,151−33.4% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 15,500 | $1.35M | 0.8% | +1,500+10.7% | Added | History |
| ELSEquity Lifestyle Properties Inc | COM | 20,611 | $1.33M | 0.8% | 00.0% | Unchanged | History |
| ACTEnact Holdings, Inc. | COM | 42,367 | $1.32M | 0.8% | 00.0% | Unchanged | History |
| MITTTPG Mortgage Investment Trust, Inc. | COM NEW | 208,879 | $1.28M | 0.8% | 00.0% | Unchanged | History |
| PRCTPROCEPT BioRobotics Corp | COM | 25,000 | $1.24M | 0.7% | +25,000 | New | History |
| IMVTImmunovant, Inc. | COM | 38,000 | $1.23M | 0.7% | 00.0% | Unchanged | History |
| AVAVAeroVironment Inc | COM | 8,000 | $1.23M | 0.7% | +8,000 | New | History |
| RVNCRevance Therapeutics, Inc. | COM | 245,000 | $1.21M | 0.7% | +25,000+11.4% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 3,000 | $1.20M | 0.7% | −750−20.0% | Reduced | History |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 27,500 | $1.18M | 0.7% | −2,500−8.3% | Reduced | History |
| SOUNSoundhound AI, Inc. | CLASS A COM | 200,000 | $1.18M | 0.7% | 00.0% | Unchanged | History |
| SYMSymbotic Inc. | Stock | 25,000 | $1.13M | 0.7% | 00.0% | Unchanged | History |
| CABACabaletta Bio, Inc. | COM | 65,000 | $1.11M | 0.7% | +65,000 | New | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 8,500 | $1.02M | 0.6% | −2,000−19.0% | Reduced | History |
| SGMTSagimet Biosciences Inc. | COM SER A | 185,000 | $1.00M | 0.6% | +185,000 | New | History |
| RWT Hldgs Inc749772AD1 | CONVERTIBLE BOND | 1,000,000 | $970.0K | 0.6% | −1,284,000−56.2% | Reduced | – |
| NBIXNeurocrine Biosciences Inc | Stock | 7,000 | $965.4K | 0.6% | +7,000 | New | History |
| ROIVRoivant Sciences Ltd. | SHS | 90,000 | $948.6K | 0.6% | +35,000+63.6% | Added | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 60,000 | $943.8K | 0.6% | +60,000 | New | History |
| LUNRIntuitive Machines, Inc. | CLASS A COM | 150,000 | $937.5K | 0.6% | +150,000 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 56,000 | $901.0K | 0.5% | 00.0% | Unchanged | History |
| RRXRegal Rexnord Corp | COM | 5,000 | $900.5K | 0.5% | +5,000 | New | History |
| ALNTAllient Inc | COM | 25,000 | $892.0K | 0.5% | +25,000 | New | History |
| ARAYAccuray Inc | COM | 350,000 | $864.5K | 0.5% | +350,000 | New | History |
| AGNCAGNC Investment Corp. | REIT | 84,646 | $838.0K | 0.5% | 00.0% | Unchanged | History |
| ACADAcadia Pharmaceuticals Inc | COM | 45,000 | $832.0K | 0.5% | +19,000+73.1% | Added | History |
| SNYSanofi | SPONSORED ADR | 15,000 | $729.0K | 0.4% | +15,000 | New | History |
| PTGXProtagonist Therapeutics, Inc | COM | 25,000 | $723.3K | 0.4% | −5,000−16.7% | Reduced | History |
| ONITOnity Group Inc. | COM NEW | 25,567 | $690.6K | 0.4% | −2,628−9.3% | Reduced | History |
| GMEDGlobus Medical Inc | Stock | 12,500 | $670.5K | 0.4% | +12,500 | New | History |
| DYNDyne Therapeutics, Inc. | COM | 20,000 | $567.8K | 0.3% | +20,000 | New | History |
| PCARPaccar Inc | COM | 4,146 | $513.6K | 0.3% | −472−10.2% | Reduced | History |
| J P Morgan Exchange Traded F46641Q217 | BETABULDRS JAPAN | 8,747 | $512.1K | 0.3% | −798−8.4% | Reduced | – |
| iShares Inc464286103 | MSCI AUST ETF | 20,694 | $510.3K | 0.3% | +506+2.5% | Added | – |
| CAHCardinal Health Inc | Stock | 4,546 | $508.7K | 0.3% | −507−10.0% | Reduced | History |
| Invesco QQQ Trust Series I46090E103 | ETF | 1,128 | $500.8K | 0.3% | −3,994−78.0% | Reduced | – |
| Invesco Nasdaq 100 ETF46138G649 | ETF | 2,740 | $500.6K | 0.3% | −9,738−78.0% | Reduced | – |
| Western Asset Mortgage Capit95790DAD7 | NOTE 6.750% 9/1 | 500,000 | $497.5K | 0.3% | 00.0% | Unchanged | – |
| VALNValneva SE | SPONSORED ADS | 62,004 | $495.4K | 0.3% | +27,706+80.8% | Added | History |
| NUVBNuvation Bio Inc. | COM CL A | 135,000 | $491.4K | 0.3% | −315,000−70.0% | Reduced | History |
| Redwood Trust Inc758075AF2 | NOTE 7.750% 6/1 | 500,000 | $481.3K | 0.3% | 00.0% | Unchanged | – |
| iShares Tr464288588 | MBS ETF | 5,000 | $462.1K | 0.3% | +5,000 | New | – |
| iShares Tr464287457 | 1 3 YR TREAS BD | 5,458 | $446.4K | 0.3% | −5,882−51.9% | Reduced | – |
| AUPHAurinia Pharmaceuticals Inc. | COM | 80,000 | $400.8K | 0.2% | +30,000+60.0% | Added | History |
| COOPMaverick Merger Sub 2, LLC | COM | 4,931 | $384.4K | 0.2% | −16,660−77.2% | Reduced | History |
| DALDelta Air Lines, Inc. | COM NEW | 7,932 | $379.7K | 0.2% | −1,059−11.8% | Reduced | History |
| PHMPultegroup Inc | COM | 3,132 | $377.8K | 0.2% | −421−11.8% | Reduced | History |
| iShares Tr464288661 | 3 7 YR TREAS BD | 3,242 | $375.5K | 0.2% | −1,326−29.0% | Reduced | – |
| Vanguard High Dividend Yield Index ETF921946406 | ETF | 3,088 | $373.6K | 0.2% | −270−8.0% | Reduced | – |
| iShares Tr46435G342 | MORTGE REL ETF | 15,954 | $370.8K | 0.2% | +177+1.1% | Added | – |
| State Street SPDR Bloomberg Convertible Securities ETF78464A359 | ETF | 4,972 | $363.2K | 0.2% | −270−5.2% | Reduced | – |
| SPDR Index Shs FDS78463X772 | ST S&P INTL ETF | 10,316 | $362.6K | 0.2% | −101−1.0% | Reduced | – |
| Invesco Exchange Traded FD T46137V399 | S&P500 BUY WRT | 16,127 | $362.5K | 0.2% | −592−3.5% | Reduced | – |
Sold out since Q4 2023 (26)
Positions held at the end of Q4 2023 that are gone from this filing.
| Security | Class | Shares in Q4 2023 | Value in Q4 2023 | % of portfolio in Q4 2023 | History |
|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 127,500 | $3.78M | 2.5% | History |
| WBAWalgreens Boots Alliance, Inc. | COM | 120,000 | $3.13M | 2.1% | History |
| ABVXAbivax S.A. | SPONSORED ADS | 267,500 | $2.86M | 1.9% | History |
| IRWDIronwood Pharmaceuticals Inc | COM CL A | 245,000 | $2.80M | 1.9% | History |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 151,000 | $2.22M | 1.5% | History |
| VSTMVerastem, Inc. | COM NEW | 150,000 | $1.22M | 0.8% | History |
| KRTXKaruna Therapeutics, Inc. | COM | 3,500 | $1.11M | 0.7% | History |
| MBLYMobileye Global Inc. | Stock | 20,000 | $866.4K | 0.6% | History |
| OMCLOmnicell, Inc. | COM | 20,000 | $752.6K | 0.5% | History |
| IRTCiRhythm Holdings, Inc. | COM | 5,000 | $535.2K | 0.4% | History |
| HOSHornbeck Offshore Services, Inc. | Stock | 50,000 | $514.0K | 0.3% | History |
| VTRSViatris Inc | Stock | 35,000 | $379.1K | 0.3% | History |
| DPRODraganfly Inc. | COM NEW | 500,000 | $239.8K | 0.2% | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 10,000 | $236.2K | 0.2% | History |
| MQYBlackRock Muniyield Quality Fund, Inc. | COM | 5,100 | $62.2K | <0.1% | History |
| MHDBlackRock Muniholdings Fund, Inc. | COM | 5,150 | $61.3K | <0.1% | History |
| MUCBlackRock Muniholdings California Quality Fund, Inc. | CEF | 5,500 | $61.2K | <0.1% | History |
| MUJBlackRock Muniholdings New Jersey Quality Fund, Inc. | COM | 5,350 | $61.0K | <0.1% | History |
| BLEBlackRock Municipal Income Trust II | COM | 5,700 | $60.9K | <0.1% | History |
| MUIBlackRock Municipal Credit Alpha Portfolio, Inc. | COM | 5,200 | $60.5K | <0.1% | History |
| NOTEFiscalNote Holdings, Inc. | COMMON STOCK | 50,000 | $57.0K | <0.1% | History |
| EIMEaton Vance Municipal Bond Fund | COM | 5,000 | $50.6K | <0.1% | History |
| NMCONuveen Municipal Credit Opportunities Fund | COM | 5,000 | $49.9K | <0.1% | History |
| NDMONuveen Dynamic Municipal Opportunities Fund | COM SHS | 5,000 | $49.5K | <0.1% | History |
| PMMFranklin Managed Municipal Income Trust | COM | 8,125 | $49.4K | <0.1% | History |
| iShares Inc464286640 | MSCI CHILE ETF | 662 | $18.7K | <0.1% | – |